Literature DB >> 25797115

Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway.

Jhi Biau Foo1, Latifah Saiful Yazan2, Yin Sim Tor3, Agustono Wibowo3, Norsharina Ismail3, Chee Wun How4, Nurdin Armania5, Su Peng Loh6, Intan Safinar Ismail7, Yoke Kqueen Cheah5, Rasedee Abdullah8.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Dillenia suffruticosa (Family: Dilleniaceae) or commonly known as "Simpoh air" in Malaysia, is traditionally used for treatment of cancerous growth including breast cancer. AIM OF THE STUDY: D. suffruticosa root dichloromethane extract (DCM-DS) has been reported to induce G0/G1 phase cell cycle arrest and apoptosis in caspase-3 deficient MCF-7 breast cancer cells. The present study was designed to investigate the involvement of p53/p21 and mitochondrial pathway in DCM-DS-treated MCF-7 cells as well as to identify the bioactive compounds responsible for the cytotoxicity of DCM-DS.
MATERIALS AND METHODS: Extraction of D. suffruticosa root was performed by the use of sequential solvent procedure. GeXP-based multiplex system was employed to investigate the expression of p53, p21, Bax and Bcl-2 genes in MCF-7 cells treated with DCM-DS. The protein expression was then determined using Western blot analysis. The bioactive compounds present in DCM-DS were isolated by using column chromatography. The structure of the compounds was elucidated by using nuclear magnetic resonance spectroscopy. The cytotoxicity of the isolated compounds towards MCF-7 cells was evaluated by using MTT assay. The percentage of betulinic acid (BA) in DCM-DS was determined by HPLC analysis.
RESULTS: The expression of p53 was significantly up-regulated at protein level. The expression of p21 at both gene and protein levels was significantly up-regulated upon treatment with DCM-DS, suggesting that the induction of G0/G1 phase cell cycle arrest in MCF-7 cells was via p53/p21 pathway. Bcl-2 protein was down-regulated with no change at the mRNA level, postulating that post-translational modification has occurred resulting in the degradation of Bcl-2 protein. Overall, treatment with DCM-DS increased the ratio of Bax/Bcl-2 that drove the cells to undergo apoptosis. A total of 3 triterpene compounds were isolated from DCM-DS. Betulinic acid appears to be the most major and most cytotoxic compound in DCM-DS.
CONCLUSION: DCM-DS induced cell cycle arrest and apoptosis in MCF-7 cells via p53/p21 pathway. In addition, DCM-DS induced apoptosis by increasing the ratio of Bax/Bcl-2. Betulinic acid, which is one of the major compounds, is responsible for the cytotoxicity of the DCM-DS. Therefore, BA can be used as a marker for standardisation of herbal product from D. suffruticosa. DCM-DS can also be employed as BA-rich extract from roots of D. suffruticosa for the management of breast cancer.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Betulinic acid; Breast cancer; Dillenia suffruticosa; Triterpene

Mesh:

Substances:

Year:  2015        PMID: 25797115     DOI: 10.1016/j.jep.2015.03.039

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  19 in total

Review 1.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance.

Authors:  Tanya Biswas; Upendra N Dwivedi
Journal:  Protoplasma       Date:  2019-07-11       Impact factor: 3.356

2.  Antitumor Activity of Betulinic Acid and Betulin in Canine Cancer Cell Lines.

Authors:  Jing Zhao; Rongfang Li; Aleksandra Pawlak; Marta Henklewska; Angelika Sysak; Lixin Wen; Jin-E Yi; Bożena Obmińska-Mrukowicz
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Exploring the Cytotoxic Effects of the Extracts and Bioactive Triterpenoids from Dillenia indica against Oral Squamous Cell Carcinoma: A Scientific Interpretation and Validation of Indigenous Knowledge.

Authors:  Maniyamma Aswathy; Kishore Banik; Dey Parama; Parameswaran Sasikumar; Choudhary Harsha; Anuja Gracy Joseph; Daisy R Sherin; Manojkumar K Thanathu; Ajaikumar B Kunnumakkara; Radhakrishnan Kokkuvayil Vasu
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-09

4.  Exploring the anti-HIV-1 reverse transcriptase, anti-inflammatory, anti-cancer activities and cytotoxicity of two fermented commercial herbal concoctions sold in Limpopo Province of South Africa.

Authors:  Matimba I Ntlhamu; Ashwell R Ndhlala; Peter Masoko
Journal:  BMC Complement Med Ther       Date:  2021-05-26

5.  Cisplatin induces HepG2 cell cycle arrest through targeting specific long noncoding RNAs and the p53 signaling pathway.

Authors:  Ping Wang; Jiayue Cui; Jihong Wen; Yunhui Guo; Liangzi Zhang; Xia Chen
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

Review 6.  Lupane-type triterpenes and their anti-cancer activities against most common malignant tumors: A review.

Authors:  M H Cháirez-Ramírez; M R Moreno-Jiménez; R F González-Laredo; J A Gallegos-Infante; Nuria Elizabeth Rocha-Guzmán
Journal:  EXCLI J       Date:  2016-11-30       Impact factor: 4.068

7.  Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.

Authors:  Zhangxiao Peng; Yan Wang; Jianhui Fan; Xuejing Lin; Chunying Liu; Yang Xu; Weidan Ji; Chao Yan; Changqing Su
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

8.  The effect of moderate exercise on the elevation of Bax/Bcl-2 ratio in oral squamous epithelial cells induced by benzopyrene.

Authors:  Anis Irmawati; Nadira Jasmin
Journal:  Vet World       Date:  2018-02-13

9.  Modified Gold Nanoparticles for Efficient Delivery of Betulinic Acid to Cancer Cell Mitochondria.

Authors:  Olakunle Oladimeji; Jude Akinyelu; Aliscia Daniels; Moganavelli Singh
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

10.  Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).

Authors:  Mohamed E M Saeed; Nuha Mahmoud; Yoshikazu Sugimoto; Thomas Efferth; Heba Abdel-Aziz
Journal:  Front Pharmacol       Date:  2018-05-15       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.